Figure 3 | Scientific Reports

Figure 3

From: Assessment of 213Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-13C]pyruvate and [18F]FDG

Figure 3

Lactate concentrations in cell culture media of LN18 (A) and EJ28Luc (B) cells 48 h after 213Bi-anti-EGFR-MAb treatment. Lactate concentrations, as determined with a commercial assay kit, did not significantly differ in untreated controls and 213Bi-anti-EGFR-MAb treated cells, both in EJ28Luc and LN18 cells. 213Bi-anti-EGFR-MAb treatment induced a slightly elevated lactate concentration in EJ28Luc cells and a negligible decrease of lactate concentration in LN18 cells. Displayed are mean ± SD.

Back to article page